VistaGen Therapeutics (NASDAQ: VTGN) Featured Research Report

5 A EGIS C APITAL C ORP. Fig. 1. VistaGen pipeline Source: VistaGen Therapeutics VistaGen Therapeutics, Inc. October 8, 2020